Health Diagnostic Startup Acculi Labs Nets Seed Funding From Sabi Holding 

Health diagnostic startup Acculi Labs has raised $1.5 Mn in a seed funding round led by Sabi Holding India Ltd.

The Bengaluru-based company plans to use the fresh capital to develop its AI insights system Lyra, micro-entrepreneurial project Lyfas Udyam and boost its JV with Sabi Holding.

It has earmarked 50% of the proceeds for the JV and the rest will be allocated to other two initiatives.

The startup also seeks to strengthen its manpower, operational efficiency, infrastructure development as well as manufacturing and production capacity.

Sabi Holding India’s co-founder Kuldeep said, “Our partnership with Acculi Labs has been instrumental in our growth. Our shared values and vision align perfectly, thereby making this investment a strategic move. We believe in Acculi’s potential and are excited about the future of our joint ventures.”

Founded in 2017 by Hari Prasath M and Rupam Das, Acculi Labs offers services like point-of-care chronic disease diagnostics, monitoring, and healing. 

Acculi Labs’ key offerings include Lyfas, a mobile application capable of non-invasively capturing psychophysiological biomarkers and delivering a detailed health report within three minutes. Besides, it runs a project called Lyfas Udyam initiative which enables an economy for small entrepreneurs to start and run their businesses. 

This comes at a time when the broader healthtech space has been gaining a lot of traction from investors for quite some time now.

For instance, earlier this month healthcare services provider Lifetime Health reportedly secured $1.5 Mn as a part of its seed funding round led by The Garage Syndicate. 

In the same month, healthcare startup Icanheal raised INR 15 Cr in a seed funding round led by IvyCap Ventures.

According to a report by Bain & Company, riding on the back of the healthcare innovation healthtech market in FY 2023, more than doubled to $ 7 Bn from from about $3 Bn in FY 2020.